JPH0678752A - New penicillium mold - Google Patents

Abstract

PURPOSE: To produce an isochroman carboxylic acid derivative by using a fungus belonging to the genus Penicillium and having an antibacterial activity and an antitumor activity.

CONSTITUTION: A fungus N990-12 having an antibacterial activity and an antitumor activity based on a gyrase-inhibiting action is separated from a soil specimen collected from a forest community near to Flagstaff in the state Arizona in USA, is named Penicillium SP-N990-12 and deposited as FERM BP-3959. An isochroman carboxylic acid derivative of the formula is obtained by inoculating the fungus in a culture medium, culturing the inoculated fungus on a rotary shaker at 26°C for 4 days, lyophilizing the culture solution, extracting the obtained dry broth with 70% acetone water, and subsequently purifying the extract by silica gel column chromatography.

COPYRIGHT: (C)1994,JPO

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a new bacterium producing a novel isochromancarboxylic acid derivative having antibacterial activity, Micro Engineering Kenjoyori No. 3959 (FERM BP-3959).

[0002]

2. Description of the Related Art Recently, bacterial topoisomerase
II (gyrace) inhibitors are attracting attention as targets for antibacterial agents. This is based on the fact that the mechanism of action of quinolone synthetic antibacterial agents that are widely used at present is mainly due to inhibition of gyrase activity. Quinolone-based synthetic antibacterial agents show a wide range of antibacterial activities, but like other antibacterial agents, the emergence of resistant bacteria gradually becomes a problem. As gyrase inhibitors produced by microorganisms, novobiocin, coumamycin A1 and the like are known, but their antibacterial spectra are narrow and do not extend to quinolone synthetic antibacterial agents as antibiotics.

[0003]

SUMMARY OF THE INVENTION An object of the present invention is to provide a bacterium which produces a novel isochroman carboxylic acid derivative having excellent antibacterial activity in which resistant bacterium hardly appears.

[0004]

The present inventors have found that the mold N990-12 isolated from a soil sample collected in a forest community near Flagstaff, Ariz., USA, is a novel isoquinone having anti-gyrase activity. It has been found to produce a Romancarboxylic acid derivative.

That is, the present invention provides a novel isochroman carboxylic acid derivative-producing bacterium as shown by the following formula.

[0006] The mycological properties of N990-12 are as follows.

N990-12 was inoculated at 1 site and 3 sites on an agar plate medium for identification from potato-glucose agar slant culture and cultured at 25 ° C. for 1 to 5 weeks. Color is Robert R
idgway's Color Standards and Color Nomenclature (19
It was judged by comparing with the color chip of 12). The medium used for identifying the strain is as follows.

1. Cornmeal Agar (CM): Carmichae
l, JW, Mycologia 49: 820-830, 1957. 2. Czapek Sucrose Agar (CZ): Raper, KB and
Fennell, DI The Genus Aspergillus, p. 36, 196
Five. 3. Malt extract agar (MEA): ibid., P. 38. 4. Czapek / Yeast Agar (CYA): Pitt, JI, Pen
icillium and Its Teleomorphic States Eupenicillium
and Talaromyces, p. 18, 1979. 5. 25% glycerin / nitrate agar (G25N): Same as above. 6. Oatmeal agar (OA): ISP medium No. 3, Difco. 7. Potato-glucose agar (PDA): ATCC medium N
o. 336, ATCC Media Handbook, p. 17, 1984. 8. V-8 juice agar: ATCC medium No. 343, ibid. 9. Phytone YEA ： BBL
. 10. Yeast extract and soluble starch agar (YPSS): Emerso
n, R., Mycologia 50, 589-621, 1958.

1. Growth state in each medium CYA (25 ° C., 7 days) reaches 4.2 cm in diameter; white to maize yellow (IV), and 11 days, pale orange to pale yellow peach color (pale ochraceous). salmon to
pale ochraceous buff (XV), the periphery is light green or light green (light celandine green to celandine g)
reen, XLVII); radial wrinkles, moderate ridges; pale yellow orange to
It produces a secretion of orange buff, III), which is 11
It becomes orange (orange, III), red-orange or dark red-orange (bittersweet orange to mars orange, II) by day;
The reverse side is dusky orient blue (XXXIV); no soluble pigment is produced.

CZ (25 ° C., 7 days) reaches 3.3 cm in diameter; grayish green (russian green, XLII), velvety, flat; backside is colorless; no soluble pigment is produced but deep orange yellow (11 days) ocharaceous orange, XV) or orange (apri
cot orange, XIV).

MEA (25 ° C., 7 days) reaches 2.7 cm in diameter; light green (celandine green, XLVII), velvety, flat; reverse side dark gray green to dark green gray (dusky blue)
-greento dusky bluish-green, XXXIII); No soluble pigment is produced.

G25 N (25 ° C., 7 days) reaches 2.1 cm in diameter; light yellow (baryta yellow, IV), 11 days light green to green gray (gnaphalium green to pea green, X)
LVII); a circular depression is created at the periphery and in the center, 1
Radially wrinkles in 1 day; medium ridges, felt-like; backside is light green (cobalt green to verdigris gr
een, XIX), but the periphery is light green-yellow (light chalcedony
yellow, XVII). On the 11th, turquoise, dark turquoise, dark gray green (porcelain green, dark porcelaingree
n, dusky blue-green, XXXIII); no soluble pigment is produced.

CYA (5 ° C., 7 days) reaches 0.8 cm in diameter; white, lightly developing, but 11 days, moderately bulging, flat, felt-like; white on the reverse side; no soluble pigment is produced.

CYA (37 ° C, 7 days) reaches 2.2 cm in diameter; white to pale olive buff,
XL), remarkably irregularly wrinkled and highly raised; backside is orange yellow, deep orange yellow to brown (warm-buff, antimony
yellow, ochraceous orange tocinnamon-brown, XV
), Dark orange yellow to dark brown on day 11 (raw sienna to
Antique brown, III); no soluble pigment produced.

CM (25 ° C., 7 days) reaches a diameter of 3.7 cm; thin, flat, velvety; colorless to sulphur yellow (V) on the reverse side; no soluble pigment is produced.

[0016] YPSS (25 ° C, 7 days) reaches a diameter of 2.9 cm; celandinegreen to artemisi
a green, XLVII) or deep bluish gra
y-green, XLII), flat, velvety; back side is colorless, buff yellow (IV), bright yellow pink to ochraceous buff to ochraceous-orange (XV); soluble pigment is not produced.

2. Morphological characteristics Morphological characteristics were observed after 7 and 11 days of culture on CYA and CZ agar. Conidia peduncles usually arise from aerial hyphae, producing smooth or sparsely roughened surfaces, 50-200 x 2-4 μm, either phialides or methotre; metore 2-4
12-20 x 2-4 μm rim, smooth or rough wall; 6 to 10 phialides per smooth surface, ampoule type with sharp tip, 7-9 x 2.0-2.5 μm; conidia spherical or spheroidal, often oval, diameter 2.5-3.
The surface was 0 μm or 3.0-3.5 x 2.5-3.0 μm, and the surface was smooth or finely rough as observed by a scanning electron microscope.

3. Good growth at growth temperatures of 15, 20, 28 ° C; moderate to good growth at 37 ° C; no growth at 45 ° C and 50 ° C.

In summary of the mycological properties, N990-12 has a monolithic or compound uniaxial penicillus, a smooth or sparsely rough conidiophore, and a smooth or finely rough wall. Characterized by conidia in the shape of a sphere or a sphere. The conidia mass is generally green in color. On CYA, MEA and G25N medium, the color of the back side of the colonies was blue to turquoise. Therefore, this strain belongs to the genus Penicillium.

[0020] This strain N990-12 has Raper and Thom (A Manual
of the Penicillia, The Williamsand Wilkins Compan
y, Baltimore, 1949) defines Pen.
icillium raistrickii series and Penicillium brevi-co
It is closely related to the mpactum series, but differs from them as follows.

N990-12 is a form of methotre and phialide,
The conidia sparsely rough surface and the shape of conidia are P. raistrickii s
Similar to the eries species, but lacking sclerotia, colony underside color, shorter conidiophores, thinner phialides, and conidial surfaces smooth or fine rather than smooth. The difference is that it is rough.

N990-12 and Penicillium brevi-compactum
The strains of the series have common growth characteristics on most of the tested media, conidial head color, morphology of methotre and phialide, and sparsely conidial stalks. Three species of this series (P. brevi-compactum, P. stoloniferum
And P. paxilli) compared to P. brevi-compactum
P. stoloniferum is a lack of lami, colony backside color, shorter conidia peduncle, generally smaller penicilli and smaller conidia. Backside color, longer metre, and P.paxilli is the backside color of the colony, longer metre, and the majority of conidia are spherical or spheroidal rather than elliptical or spheroidal. Each is different.

From the above properties, N990-12 was named as Penicillium sp. Because it did not match any of the described species of the genus Penicillium. This is Penicillium SPN990-12
(Penicillium sp. N990-12) is displayed.
No. 9 (FERM BP-3959) was deposited under the Budapest Treaty on July 31, 1992.

[Culture of Bacteria] Cultivation of the strain of the present invention is preferably carried out as follows. For small-scale culture,
First, put an appropriate amount of nutrient medium in a flask and sterilize it by a known method, then inoculate this flask with N990-12 spores or vegetatively growing cells, and incubate on a rotary shaker at a constant room temperature of about 26 ° C. Incubate for 2 to 10 days. For large-scale culture, it is desirable to carry out in an appropriately sized tank equipped with a stirrer, aeration device and sterilization device. The nutrient medium is prepared in a tank, sterilized and inoculated with N990-12 spores or vegetative cells. The pH of the medium is 5 to 9, preferably
6 to 8 is preferable. The culturing is carried out at a temperature in the range of about 20 to 40 ° C. for about 2 to 10 days with stirring and / or aeration of the nutrient medium. The degree of aeration needs to be varied depending on several factors (eg incubator size, agitation speed, etc.). Generally, it is desirable to carry out agitation at 0 to 2,000 rpm, preferably 100 to 360 rpm, and aeration by blowing air at 0 to 500%, preferably 80 to 120% of the medium volume per minute.

[Product Recovery] The novel isochromancarboxylic acid derivative can be recovered from the whole culture broth by solvent extraction and various chromatographic techniques. The substance is only slightly soluble in water, but soluble in organic solvents. Utilizing this property, the novel isochromancarboxylic acid derivative can be easily recovered. For example, the whole culture is extracted with a water-immiscible solvent such as chloroform, ethyl acetate, methyl isobutyl ketone. These extracts are dried and concentrated by a known method, and then subjected to various chromatographies. An example is column chromatography in which a medium such as silica gel, reversed-phase silica gel, alumina oxide, or dextran gel is used, and these columns are combined with various solvents and / or two or more solvents at different ratios and eluted. . Liquid chromatography and thin layer chromatography are convenient for the detection of isochromancarboxylic acid derivatives. Its presence can be determined by measuring the antibacterial and anti-gyrase activities of various chromatographic fractions as described below.

[Measurement of Activity] The gyrase inhibitory activity of the novel isochromancarboxylic acid derivative is measured by a known method using gyrase derived from Escherichia coli (Mizuuchi, K.,
O'dea, MH, andGellert, M., Proc. Natl. Acad. Sc
i. USA, 75, 5960-5963, 1978). The eukaryotic cell-derived topoisomerase II inhibitory activity was measured according to the method instructed by the manufacturer (US Biochemical Corporation) using commercially available Drosophila-derived topoisomerase II. The inhibitory activity (IC ₅₀ value) of the novel isochromancarboxylic acid derivative against gyrase and topoisomerase II was 3 μg / ml and 1 μg / ml, respectively.
It was less than ml. These biological activities suggest that the isochromancarboxylic acid derivative is useful as an antitumor agent as well as an antibiotic agent. This is based on that the mechanism of action of some of the widely used antitumor agents is due to inhibition of topoisomerase II activity (References Znang, HD, D'Arpa, P. and Liu,
LF, Cancer Cells, 2, 23-26, 1990).

The antibacterial activity of the novel isochroman carboxylic acid derivative can be measured by a standard method (Ericsson, HM and Scherr).
is, JC, Acta Pathol. et Microbiol. Suppl. 217B,
64-68, 1971), and agar plate dilution method using BHI medium (pH 7.4). Table 1 shows the minimum inhibitory concentration of the novel isochromancarboxylic acid derivative for each test bacterium.
Shown in.

[0028]

[Table 1] Minimum inhibitory concentration of test bacteria (μg / ml) Staphylococcus aureus 01A005 25 (Staphylococcus aureus) Staphylococcus aureus 01A063 50 (Staphylococcus aureus) # Staphylococcus epidermides 01B087 50 (Staphylococcus epidermides) 100 (Enterococcus faecalis) Streptococcus piogenes 02C054 50 (Streptococcus pyogenes) Escherichia coli Martocida 59A001 100 (Pasturella multocida) Serratia marcescens 63A017> 100 (Serratia marcescens) Enterobacter aerogenes 67A040> 100 (Enterobacter aerogenes) Enterobacter acrogenes 67B00 9> 100 (Enterobacter cloacae) Providencia sturarch 77A013> 100 (Providencia stuartii) Providencia retgeri 77C025> 100 (Provedencia rettgeri) Morganella morgani 97A001> 100 (Morganella morganii) # Ciprofloxacin resistant bacteria

[0029]

INDUSTRIAL APPLICABILITY The novel isochroman carboxylic acid derivative produced by the bacterium of the present invention is orally administered to prevent or treat diseases of humans and other animals caused by a wide range of pathogens including the bacteria shown in Table 1. It can be administered by either parenteral or topical routes. In general, the most desirable dosage of these compounds will be between about 300 mg and about 3000 mg per day, but will of course vary with the weight and condition of the patient and the particular route of administration. However, about 1 kg of body weight per day
A dose of 5 mg to about 50 mg is most desirable. When administered to animals, the dose varies depending on the type of animal to be treated, the difference in sensitivity of the animal to the drug, the method of prescribing the drug, the administration period and the administration interval. In some cases, a dose lower than the lower limit of the above range may be appropriate, and even if the dose is higher than the above range, it may cause harmful side effects if it is administered in small doses divided into multiple doses per day. It may not be.

The novel isochroman carboxylic acid derivative can be administered alone or with a pharmaceutically acceptable carrier or diluent by any of the above three administration routes, and the administration can be performed once or several times. It can be done separately. More specifically, it can be administered in various types of dosage forms, for example, tablets, capsules, medicated drops, troches, hard candy, powders in combination with various pharmaceutically acceptable inert carriers. Agent, spray,
It can be in the form of cream, salve, suppository, jelly, gel, paste, lotion, ointment, aqueous suspension, injection, elixir, syrup and the like. These carriers include solid diluents or excipients, sterile aqueous media, various non-toxic organic solvents and the like. In the case of a drug for oral administration, it may be optionally sweetened and / or flavored. Generally, the therapeutically active compounds of this invention are administered in a concentration range of about 5% to 70% by weight in the form as described above.

For oral administration, various excipients such as microcrystalline cellulose, sodium citrate, calcium carbonate, dipotassium phosphate, glycine are added to the starch, preferably corn, potato or tapioca starch, and alginic acid or It can be used with various disintegrants such as certain silicic acid double salts, and granulating binders such as polyvinylpyrrolidone, sucrose, gelatin, acacia. Lubricants such as magnesium stearate, sodium lauryl sulfate and talc are also often very effective in tablet formation. The same type of solid composition can be used by filling a gelatin capsule. Suitable substances in this connection include lactose or milk sugar as well as high molecular weight polyethylene glycols. When it is desired to prepare an aqueous suspension and / or elixir for oral administration, the active ingredient is used in combination with various sweetening agents or flavoring agents, coloring agents or dyes, and if necessary, an emulsifying agent and / or suspending agent. However, it can be used with diluents such as water, ethanol, propylene glycol, glycerin, and the like, and combinations thereof.

For parenteral administration, the novel isochroman carboxylic acid derivative can be dissolved in either sesame oil or peanut oil, or a solution prepared by dissolving it in an aqueous propylene glycol solution can be used. The aqueous solution should be suitably buffered (preferably pH 8 or higher) as needed and the liquid diluent first rendered isotonic. Such aqueous solutions are suitable for intravenous injection, oily solutions for intra-articular, intramuscular and subcutaneous injection. Aseptic preparation of all of these solutions can be readily accomplished by standard pharmaceutical techniques well known to those skilled in the art. Furthermore, the novel isochroman carboxylic acid derivative can also be topically administered to the skin or the like. In this case, topical administration in the form of creams, jellies, pastes, ointments is desirable according to standard pharmaceutical practice.

[0033]

EXAMPLES The present invention will be described below with reference to examples, but the present invention is not limited to matters specified in detail in these examples. The melting points used in the examples are Yanaco's micro melting point measuring device (uncorrected), the optical rotations are JASCO's DIP-370 digital polarimeters, and the ultraviolet absorption spectra are in methanol solution, JASCO's spectrophotometers ( Ubest-30), the infrared absorption spectrum was measured by Shimadzu infrared spectrophotometer (IR-470). Unless otherwise specified, ¹ H and ¹³ C nuclear magnetic resonance spectra (NMR) were measured by a solution of deuterated chloroform (CDCl ₃ ) by a JEOL nuclear magnetic resonance apparatus (JNM-GX270, 270 MHz). It is a thing. The peak position is expressed from tetramethylsilane to the downfield in units of 1,000,000 (ppm). The peak shape is expressed as follows.
s: singlet, d: doublet, t: triplet, m: multiplet, br: broad. The EI mass spectrum was measured with a Hitachi mass spectrometer (model M-80), and the HRFAB mass spectrum was measured with a Kratos mass spectrometer (model 1S) using a NaI matrix.

Example 1 Medium 1 (glucose 2%, polypeptone 3%, meat extract
0.3%, yeast extract 0.5%, blood meal 0.3%, Ca
Inoculate a 500 ml Erlenmeyer flask containing 100 ml of CO ₃ 0.4%, pH 7.0) with Penicillium sp. N990-12.
This flask was cultivated on a rotary shaker having a diameter of 7 cm and rotating at 220 rpm at 26 ° C. for 4 days to obtain a first seed culture solution.

7.5 ml of the first seed culture is inoculated into 5 500 ml Erlenmeyer flasks containing 150 ml of the medium 1. This flask was cultivated on a rotary shaker having a diameter of 7 cm and rotating at 220 rpm at 26 ° C. for 4 days to obtain a second seed culture solution.

Medium 2 (1% glucose, corn starch
2%, Enuzetto amine 0.5%, 0.5% wheat germ, 0.5% yeast _{extract, CoCl 2 · 6H 2 O 0.00001} %, CaCO 3 0.4
%, PH 7.2) into 5 6 L glass fermenters containing 3 L each of 150 ml of the second seed culture. This fermenter is ventilated at 3 L / min, rotation speed 1700 rpm,
Stir at 26 ° C for 72 hours.

After completion of the culture, freeze-dry 15 L of the whole culture solution,
The dried broth obtained is extracted with 5 L of 70% aqueous acetone.
After removing acetone under reduced pressure, the mixture was extracted twice with 2 L of ethyl acetate, and the obtained ethyl acetate extract was dehydrated with anhydrous sodium sulfate and concentrated to dryness. An oily residue containing 3.0 g of the novel isochromancarboxylic acid derivative is obtained. This oily substance
Chromatograph on a column packed with 200 g of silica gel. Elute the column sequentially with 1000 ml of chloroform, chloroform-methanol (9: 1), and methanol. The methanol elution fractions are collected, concentrated, and subjected to 1.2 L Sephadex LH-20 column chromatography packed with methanol. The active fractions eluted with methanol are collected and concentrated to dryness to obtain 209 mg of crude powder. Of this, 75 mg is placed on 5 thin-layer chromatography plates (Kieselgel 60 F-254, 20 cm X 20 cm, 0.25 mm) and developed with chloroform-methanol (3: 1). The band showing UV absorption is collected to obtain 62 mg of the novel isochromancarboxylic acid derivative as a white powder. The product was 3-n-heptyl-1,6,8-trihydroxyisochroman-7-carboxylic acid represented by the above formula.

Properties: White powder Molecular formula: C ₁₇ H ₂₄ O ₆ HRFAB-Mass spectrum: [m / z, (M + H) ⁺ -H ₂ O] 307.15
44 (calculated value 307.1545) Melting point:> 145 ° C (decomposition) Specific rotation: [α] D (24 ° C) +32.36 (c = 0.13, MeOH) UV absorption spectrum (nm) λ (ε): 214.5 (29700) ), 2
15.5 (sh), 252.0 (9700), 307.0 (4600) TLC (Rf): 0.28 (CHCl ₃ / CH ₃ OH, 3: 1, Merck Kieselgel 60 F254, Art, 5719); 0.47 (MeOH / H ₂ O, 3: 1, Merck HPTLC RP-18 F254S, Art, 13724) ¹ H NMR (CD ₃ OD): 6.02 (1H, s), 5.49 (1H, s), 4.04
(1H, m), 2.56 (1H, dd, J = 4.0, 16.9 Hz), 2.46 (1H,
dd, J = 10.6, 16.9 Hz), 1.58 (2H, br), 1.50 (1H,
m), 1.3 -1.4 (9H, m), 0.90 (3H, t, J = 6.6 Hz) ¹³ C NMR (CD ₃ OD): 178.8 (s), 163.6 (s), 161.8 (s),
141.8 (s), 113.5 (s), 106.5 (d), 104.0 (s), 98.0
(d), 68.4 (d), 37.5 (t), 36.2 (t), 33.8 (t), 31.5
(t), 31.2 (t), 27.6 (t), 24.5 (t), 15.2 (q).

Example 2 The first seed culture of Penicillium sp. N990-12 obtained in Example 1 was added to Medium 2 (100 ml) of Example 1 5
Inoculate 5 ml into a 00 ml Erlenmeyer flask. The flask is cultivated on a rotary shaker having a diameter of 7 cm and rotating at 220 rpm at 28 ° C. for 3 days. The obtained 100 ml culture broth contains the novel isochroman carboxylic acid derivative and has anti-gyrase activity. The substance can be isolated in the same manner as in Example 1.

─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. ⁵ Identification number Office reference number FI technical display location (C12P 17/06 C12R 1:80)

Claims (1)

[Claims] Claims: 1. Penicillium sp. (Penicill) deposited as Micro Works Research Article No. 3959 (FERMBP-3959) for producing isochroman carboxylic acid derivatives.
ium sp.) N990-12.